SFM
TRAW icon

Sphera Funds Management’s Traws Pharma TRAW Stock Holding History

Sphera Funds Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2
Closed -$1.38M – 138
2013
Q4 		$1.38M Buy
+2
New +$1.89M 0.38% 62

Other funds holding TRAW

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sphera Funds Management's TRAW Position: Q1 2014 in Review

Sphera Funds Management sold out of Traws Pharma (TRAW) in Q1 2014, closing a stake of 2 shares — an estimated $1.38M sold.

Sphera Funds Management first reported a position in TRAW in Q4 2013 and held it in 1 quarter. The position peaked at $1.38M in Q4 2013. 16 funds tracked by Wall St. Rank hold TRAW as of Q1 2014.

  • Sphera Funds Management reported no remaining Traws Pharma position as of Q1 2014 after selling out during the quarter.
  • Sphera Funds Management sold 2 Traws Pharma shares in Q1 2014, an estimated $1.38M.
  • Sphera Funds Management first reported a position in Traws Pharma in Q4 2013 and held it in 1 quarter.
  • Sphera Funds Management's Traws Pharma position peaked at $1.38M in Q4 2013.
  • 16 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2014.

Based on Sphera Funds Management's 13F filing for Q1 2014, filed 14 May 2014.